Effects of novel Coronavirus (COVID-19) on presentation, management, and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during COVID-19.
Autor: | Peters NV; Yale School of Medicine, Department of Surgery, PO Box 208062, New Haven, CT 06520, USA., O'Connor R; Yale School of Medicine, Department of Surgery, PO Box 208062, New Haven, CT 06520, USA., Bhattacharya B; Yale School of Medicine, Department of Surgery, PO Box 208062, New Haven, CT 06520, USA.; VA Connecticut Medical Center, Department of Surgery, Bldg 1, 4th Floor, 950 Campbell Avenue, West Haven, CT 06516, USA., Kunstman JW; Yale School of Medicine, Department of Surgery, PO Box 208062, New Haven, CT 06520, USA.; VA Connecticut Medical Center, Department of Surgery, Bldg 1, 4th Floor, 950 Campbell Avenue, West Haven, CT 06516, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Heliyon [Heliyon] 2023 Nov 04; Vol. 9 (11), pp. e22043. Date of Electronic Publication: 2023 Nov 04 (Print Publication: 2023). |
DOI: | 10.1016/j.heliyon.2023.e22043 |
Abstrakt: | Background: The COVID-19 pandemic necessitated adjustments to nearly all aspects of healthcare, including surgical care. The effects of these adjustments have not been well studied on acute surgical problems conventionally managed non-electively in large, tertiary care centers. Methods: A retrospective analysis of admitted patients with acute cholecystitis at a US academic tertiary care center was performed. We compared the presentation, management, and 30-day outcomes of patients admitted during a 2-month time period during early COVID, to a pre-COVID control group of admitted cholecystitis patients over a 2-month span. Results: The study cohort captured 24 patients, while the control cohort encompassed 53 patients. A non-significant trend toward non-operative management in the COVID cohort is reported. There was no delay in time-to-surgery or complication rate. No surgically managed patient developed COVID within 30 days of operation. Conclusions: Operative management of acute cholecystitis during the COVID-19 pandemic, with pre-operative testing and personal protective equipment guidelines, remained safe and effective. Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Published by Elsevier Ltd.) |
Databáze: | MEDLINE |
Externí odkaz: |